Physician profile
Gavin Hollyer
NPI 1336981679
$2,073.29
in general payments reported to CMS, 2019-2025
8 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $655 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $501.32 | 2024-2025 | Acthar |
| Bausch & Lomb Americas INC. | $446.10 | 2024-2025 | Xiidra, Miebo, Infuse |
| Alcon Vision LLC | $358.92 | 2024-2025 | Dailies Total1, Precision 7, Tryptyr |
| Biotissue Holdings INC. | $224.39 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $197.40 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $168.76 | 2025 | Photrexa Viscous and Photrexa |
| Coopervision INC. | $134.72 | 2024 | Paragon Crt, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $41.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Hollyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.